Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypothalamic Estrogen Signaling and Adipose Tissue Metabolism in Energy Homeostasis. | Front Endocrinol (Lausanne) | 2022 | 35757435 | PubTator, text mining | PubMed |
| Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells. | Front Cell Dev Biol | 2022 | 35756991 | PubTator, text mining | PubMed |
| Role of β3-Adrenergic Receptor in Bone Marrow Transplant as Therapeutical Support in Cancer. | Front Oncol | 2022 | 35756654 | PubTator, text mining | PubMed |
| CLSTN3 gene variant associates with obesity risk and contributes to dysfunction in white adipose tissue. | Mol Metab | 2022 | 35753632 | PubTator, text mining | PubMed |
| The different effects of intramuscularly-injected lactate on white and brown adipose tissue in vivo. | Mol Biol Rep | 2022 | 35753026 | PubTator, text mining | PubMed |
| Impact of Mirabegron Administration on the Blood Pressure and Pulse Rate in Patients with Overactive Bladder. | Medicina (Kaunas) | 2022 | 35744088 | PubTator, text mining | PubMed |
| Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery. | Sci Rep | 2022 | 35739305 | PubTator, text mining | PubMed |
| Loss of adipose TET proteins enhances β-adrenergic responses and protects against obesity by epigenetic regulation of β3-AR expression. | Proc Natl Acad Sci U S A | 2022 | 35737830 | PubTator, text mining | PubMed |
| IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting. | Nat Rev Rheumatol | 2022 | 35729334 | PubTator, text mining | PubMed |
| The Regulation of Adipose Tissue Health by Estrogens. | Front Endocrinol (Lausanne) | 2022 | 35721736 | PubTator, text mining | PubMed |
| Single-nucleotide Polymorphisms in Medical Nutritional Weight Loss: Challenges and Future Directions. | J Transl Int Med | 2022 | 35702183 | PubTator, text mining | PubMed |
| Remodeling of gene regulatory networks underlying thermogenic stimuli-induced adipose beiging. | Commun Biol | 2022 | 35701601 | PubTator, text mining | PubMed |
| Imaging Adipose Tissue Browning using Mitochondrial Complex-I Tracer [18F]BCPP-EF. | Contrast Media Mol Imaging | 2022 | 35694709 | PubTator, text mining | PubMed |
| Immune Regulator Retinoic Acid-Inducible Gene I (RIG-I) in the Pathogenesis of Cardiovascular Disease. | Front Immunol | 2022 | 35693778 | PubTator, text mining | PubMed |
| Selectivity and Maximum Response of Vibegron and Mirabegron for β3-Adrenergic Receptors. | Curr Ther Res Clin Exp | 2022 | 35693456 | PubTator, text mining | PubMed |
| Different lipid metabolic profiles and their associated genes in sessile serrated adenoma or polyps compared to hyperplastic polyps. | Am J Cancer Res | 2022 | 35693083 | PubTator, text mining | PubMed |
| Regulation of Adipose Tissue Biology by Long-Chain Fatty Acids: Metabolic Effects and Molecular Mechanisms. | J Obes Metab Syndr | 2022 | 35691686 | PubTator, text mining | PubMed |
| miR-375 is cold exposure sensitive and drives thermogenesis in visceral adipose tissue derived stem cells. | Sci Rep | 2022 | 35688898 | PubTator, text mining | PubMed |
| Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial. | Int J Clin Pract | 2022 | 35685566 | PubTator, text mining | PubMed |
| The Efficacy of Mirabegron in Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis. | Int J Clin Pract | 2022 | 35685505 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=32